Editas Medicine, Inc. (EDIT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Editas Medicine, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.14x | -0.44x | -5.02x | -2.76x | -9.33x | -35.43x |
| P/B Ratio | 6.67x | 0.78x | 2.20x | 1.69x | 3.24x | 10.44x |
| P/S Ratio | 4.49x | 3.24x | 9.85x | 30.90x | 70.28x | 45.29x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 92.2% | 67.9% | 80.2% | -74.1% |
| Operating Margin | -245.2% | -777.2% | -216.6% | -1146.3% | -756.1% | -148.6% |
| Net Margin | -395.0% | -733.7% | -196.1% | -1118.3% | -753.6% | -127.8% |
| EBITDA Margin | -366.8% | -721.4% | -208.8% | -1114.1% | -736.3% | -144.3% |
| Liquidity | ||||||
| Current Ratio | 3.54x | 3.75x | 5.39x | 5.94x | 10.82x | 7.20x |
| Quick Ratio | 3.54x | 3.75x | 5.39x | 5.94x | 10.82x | 7.20x |
| Leverage | ||||||
| Debt/Equity | 2.81x | 0.26x | 0.14x | 0.12x | 0.05x | 0.07x |
YoY = year-over-year change. Source: FMP..